ConjuChem

ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Quebec, Canada^[1] which is credited with inventing the experimental peptide hormone CJC-1295.^[2][3]

ConjuChem Biotechnologies Inc.

Company type	Public (TSX has Delisted this Stock)
Industry	Biotechnology
Headquarters	Montreal, Quebec , Canada
Key people	Mark Perrin
Products	Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC)
Number of employees	44[citation needed][needs update]
Website	www.conjuchem.com

It employs 45 people, 90% of whom are in research and development.^{[citation needed][needs update]}